On November 27, 2023, Centrexion Therapeutics Corporation closed the transaction. The transaction included participation from two investors.
Centrexion Therapeutics Corporation
Equities
CNTX
US15643W1009
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+45.31% | 54.63B | |
-7.01% | 39.92B | |
+37.07% | 38.82B | |
+13.18% | 26.86B | |
-11.17% | 26.22B | |
-21.63% | 18.78B | |
+25.92% | 12.21B | |
+0.67% | 12.16B | |
+25.71% | 11.94B |